Kane Biotech Inc
XTSX:KNE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kane Biotech Inc
XTSX:KNE
|
CA |
|
P
|
PayPoint plc
F:PAN
|
UK |
|
R
|
Repsol SA
XBER:REP
|
ES |
|
A
|
Altair Resources Inc
OTC:AAEEF
|
CA |
Shareholder Yield
Current shareholder yield for KNE is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
KNE Price
Kane Biotech Inc
| Average Annual Return | -5.81% |
| Standard Deviation of Annual Returns | 33.38% |
| Max Drawdown | -89% |
| Market Capitalization | 6.2m CAD |
| Shares Outstanding | 205 060 000 |
| Percentage of Shares Shorted | 0.03% |
KNE Return Decomposition
Main factors of price return
Stock Splits
KNE's latest stock split occurred on Mar 13, 2017
The company executed a 1-for-5 stock split, meaning that for every 5 shares held, investors received 1 new share.
Before the split, KNE traded at 0.03 per share. Afterward, the share price was about 0.13.
The adjusted shares began trading on Mar 13, 2017. This was the only stock split in KNE's history.
